Learn More About BIOVECTRA!
BIOVECTRA is a North American CDMO specializing in clinical-to-commercial scale production capabilities for biologics, synthetic small molecules, nucleic acids like pDNA and mRNA, highly potent APIs, bioreagents
Our teams, backed by 50+ years of experience and a proven track record of excellence, optimize, adapt, and perfect innovative technologies and drug substance development approaches to deliver world-class solutions for pharmaceutical manufacturing.
BIOVECTRA is a 2025 Biologics CDMO Leadership Award winner!
